Cargando…
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927600/ https://www.ncbi.nlm.nih.gov/pubmed/33680951 http://dx.doi.org/10.3389/fonc.2020.626836 |
_version_ | 1783659707249983488 |
---|---|
author | Kalathil, Dhanya John, Samu Nair, Asha S. |
author_facet | Kalathil, Dhanya John, Samu Nair, Asha S. |
author_sort | Kalathil, Dhanya |
collection | PubMed |
description | Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a cell, FOXM1 turns out to be a bane by manifesting in several disease scenarios including cancer. It has been given an oncogenic status based on several evidences indicating its role in tumor development and progression. FOXM1 is highly expressed in several cancers and has also been implicated in poor prognosis. A comprehensive understanding of various aspects of this molecule has revealed its role in angiogenesis, invasion, migration, self- renewal and drug resistance. In this review, we attempt to understand various mechanisms underlying FOXM1 gene and protein regulation in cancer including the different signaling pathways, post-transcriptional and post-translational modifications. Identifying crucial molecules associated with these processes can aid in the development of potential pharmacological approaches to curb FOXM1 mediated tumorigenesis. |
format | Online Article Text |
id | pubmed-7927600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79276002021-03-04 FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis Kalathil, Dhanya John, Samu Nair, Asha S. Front Oncol Oncology Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a cell, FOXM1 turns out to be a bane by manifesting in several disease scenarios including cancer. It has been given an oncogenic status based on several evidences indicating its role in tumor development and progression. FOXM1 is highly expressed in several cancers and has also been implicated in poor prognosis. A comprehensive understanding of various aspects of this molecule has revealed its role in angiogenesis, invasion, migration, self- renewal and drug resistance. In this review, we attempt to understand various mechanisms underlying FOXM1 gene and protein regulation in cancer including the different signaling pathways, post-transcriptional and post-translational modifications. Identifying crucial molecules associated with these processes can aid in the development of potential pharmacological approaches to curb FOXM1 mediated tumorigenesis. Frontiers Media S.A. 2021-02-15 /pmc/articles/PMC7927600/ /pubmed/33680951 http://dx.doi.org/10.3389/fonc.2020.626836 Text en Copyright © 2021 Kalathil, John and Nair http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kalathil, Dhanya John, Samu Nair, Asha S. FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title | FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title_full | FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title_fullStr | FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title_full_unstemmed | FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title_short | FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis |
title_sort | foxm1 and cancer: faulty cellular signaling derails homeostasis |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927600/ https://www.ncbi.nlm.nih.gov/pubmed/33680951 http://dx.doi.org/10.3389/fonc.2020.626836 |
work_keys_str_mv | AT kalathildhanya foxm1andcancerfaultycellularsignalingderailshomeostasis AT johnsamu foxm1andcancerfaultycellularsignalingderailshomeostasis AT nairashas foxm1andcancerfaultycellularsignalingderailshomeostasis |